BTS
CRL icon

BB&T Securities’s Charles River Laboratories CRL Stock Holding History

BB&T Securities’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.05M Buy
7,917
+1,556
+24% +$209K 0.01% 779
2019
Q2 		$902K Buy
6,361
+315
+5% +$42.7K 0.01% 858
2019
Q1 		$878K Buy
6,046
+697
+13% +$91.6K 0.01% 852
2018
Q4 		$605K Sell
5,349
-305
-5% -$38.2K 0.01% 913
2018
Q3 		$760K Buy
5,654
+2,750
+95% +$339K 0.01% 912
2018
Q2 		$326K Buy
2,904
+76
+3% +$8.22K ﹤0.01% 1243
2018
Q1 		$301K Buy
2,828
+256
+10% +$27.6K ﹤0.01% 1237
2017
Q4 		$281K Sell
2,572
-104
-4% -$11.3K ﹤0.01% 1211
2017
Q3 		$289K Buy
+2,676
New +$275K ﹤0.01% 1175

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return